Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Hailing Pharmaceutical is a core subsidiary of the Yangtze River Pharmaceutical Group (YRPG), located in the Nanjing Economic and Technological Development Zone. The company specializes in the research, development, and large-scale production of high-end pharmaceutical preparations, with a strong focus on oncology, gastroenterology, and anti-infective therapeutic areas. It operates advanced, GMP-certified manufacturing lines for various dosage forms, including tablets, capsules, and small-volume injections. As a key industrial base for its parent group, Nanjing Hailing is instrumental in the commercialization of both high-quality generic drugs and innovative small molecule therapies. The company is recognized for its integration of modern manufacturing technology with rigorous quality control systems to serve both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical.